Cell-free oxygen carriers in organ perfusates
Removing red cells from a perfusate changes the oxygen-carrying architecture. The research task is to characterize the resulting system and test its function under the conditions of a defined organ protocol.
Define the complete perfusate system
A perfusate is more than its oxygen carrier. Formulation, carrier concentration, flow, gas input, temperature and the organ model all contribute to the experiment. A product label or a hemoglobin concentration alone does not describe the complete operating conditions.
BHOC, Biological Hemoglobin Oxygen Carrier, is being developed as a cell-free oxygen-delivery platform. Historical acellular or hemoglobin-based-carrier studies provide context, while a BHOC formulation needs independent characterization.
Compare function rather than names alone
A useful comparison asks what each perfusate delivers and what the organ extracts under defined conditions. The current kidney RBC-storage analysis illustrates why respiratory rate and diffusion-related measurements can be distinct readouts. It did not test BHOC.
Historical kidney and liver carrier publications offer further source routes. They should be appraised by product, model, comparator and endpoint rather than pooled into a claim that every cell-free perfusate performs alike.
Connect carrier characterization to organ response
The existing research programme proposes measuring oxygen-affinity curves and release under controlled temperature and pH conditions. Methemoglobin, oxidative stress and vascular response belong beside oxygen content and consumption.
Energy state and organ-specific function then help test whether the observed transport behaviour is useful in that model. A favourable biochemical result alone does not establish a safe transplant procedure or a recipient outcome.
- Describe the formulation, concentration and comparator.
- Report flow, gas conditions, temperature and pH.
- Measure delivery, extraction and consumption with their units.
- Keep organ function, injury and later recipient outcomes distinct.
Characterize the cold-to-warm transition
The transplant journey includes cooling, organ-centre support and rewarming. A carrier’s affinity and release cannot be assumed to remain unchanged across those stages. Historical HBOC-201 P50 near 40 mmHg is described at 37°C, not across the entire range.
A cold-to-warm programme therefore needs stage-specific measurements and predefined transitions. The question is whether the proposed system supports a measured organ function under those conditions.
One organ, one protocol, one measurable question
An initial collaboration can specify a kidney or liver model, a characterized formulation, appropriate controls and the measurements the team can perform. This creates a reviewable experiment rather than an assumption of clinical equivalence.
The historical catalogue and the related-evidence platform remain separate source collections. Neither catalogue inclusion nor an experimental design establishes BHOC transplant efficacy or an indication.